We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Phase I BP Interferon (IFN) Beta-001

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02515695
Recruitment Status : Completed
First Posted : August 5, 2015
Last Update Posted : August 6, 2015
BioPartners GmbH
Information provided by (Responsible Party):
Prof. Jérôme Biollaz, MD, Centre Hospitalier Universitaire Vaudois

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2005
Actual Study Completion Date : July 2005